Polish student’s research looks for clues to Parkinson’s Disease
by Chris Jarvis
Ewa Nowara, a junior Biophysics major and a citizen of Poland, had wanted very much to perform undergraduate research at St. Mary’s. However, because most undergraduate research is funded by federal agencies whose primary mission is to aid American students, professors are often bound by strict hiring criteria that exclude international students.
S. Colette Daubner, Ph.D., associate professor of Biological Sciences, wasn’t one to let a technicality stop a deserving student from pursuing her passion. She invited Nowara into her lab and helped her apply for and win a $3,000 grant by the Parkinson’s Disease Foundation so she could be compensated for her work.
“I enjoy the challenge,” Nowara said. “You don’t know what you’re going to find out. You don’t know how you’re going to do it; you have to figure that out on your own. You don’t learn these things in class because nobody really knows the answers that’s why we have research.”
Now, Nowara works with Daubner in the lab probing the inner workings of tyrosine hydroxylase, an enzyme that helps synthesize neurotransmitters in the brain. Together they investigate the involvement of a protein called 14-3-3, which is believed to protect tyrosine hydroxylase from breakdown in the body.
Because low levels of tyrosine hydroxylase may be linked to Parkinson’s disease, the medical community has a vested interest in understanding more about the enzyme. And Nowara’s work could provide answers.
“If we can understand this structure and the way tyrosine hydroxylase works in the body, we can design treatments and understand what’s happening to patients with Parkinson’s.”
Even though her grant term has expired, Nowara has no intention of halting her research; she continues to put in 12 to 15 hours a week in the lab voluntarily, at least until more grants come along.
Nowara said her research experience so far has been terrific preparation for her goal of attending medical school. “I’m just a junior so there’s still a lot to learn,” she said. “I just hope I can do something that is clinically relevant.”